doi: 10.3109/13880209.2013.876053 128 SaudSMLiWGrayZMatterMSColburnNHYoungMRet al
Now lets add all of this to a flowchart: Reduce Androgen Receptors: Summary When it comes to reducing DHT by decreasing androgen receptors, there are three major ways we can go about doing this: Decrease total androgen production Decrease androgen receptor expression Block androgen receptors Heres a summary of the major mechanisms behind each way: Again, this article series is only here to present a handful of angles and mechanisms for DHT reduction
This process yields a small amount of energy in the form of ATP (adenosine triphosphate), the primary energy currency of the cell, in which the energy is stored in the form of Phosphate bonds
Phase 2 trial (NEJM, 2023) The landmark Phase 2 trial, published in the New England Journal of Medicine, randomized 338 adults with obesity to receive weekly subcutaneous retatrutide at doses of 1 mg, 4 mg, 8 mg, or 12 mg, or placebo, for 48 weeks
Genes Cancer 2 , 10611066 (2011)
This guide breaks down every meaningful difference between tirzepatide and retatrutide, from receptor pharmacology to clinical trial results, dosing protocols , side effect profiles, and practical availability